Alzheimer’s Disease: A Suitable Case for Treatment with Precision Medicine?

• Published in: Medical principles and practice Vol. 33; no. 4; pp. 301 - 309
• Main Authors: Pauwels, Ernest K.J., Boer, Gerard J.
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01.08.2024
• Subjects: Alzheimer's disease; Apolipoproteins; Biomarkers; Brain research; Cyclin-dependent kinases; Design; Drug dosages; Enzymes; Health risk assessment; Kinases; Lipids; Pathogenesis; Patients; Peptides; Precision medicine; Proteins; Review; Antioxidants; Antibodies; Therapy; Small molecules; Alzheimer's disease; Gene editing

Abstract Alzheimer’s disease (AD) is the most common cause of neurodegenerative impairment in elderly people. Clinical characteristics include short-term memory loss, confusion, hallucination, agitation, and behavioral disturbance. Owing to evolving research in biomarkers, AD can be discovered at ea...